2019
DOI: 10.1111/1440-1681.13048
|View full text |Cite
|
Sign up to set email alerts
|

The role of galectin‐3 in heart failure and cardiovascular disease

Abstract: Summary Galectin‐3, a β‐galactoside‐binding lectin, is a new important player in the progression of heart failure (HF) and is also linked to poor outcome in patients with cardiovascular disease. Genetic or pharmacological inhibition of galectin‐3 slows down the progression of myocardial inflammation, reduces collagen production, attenuates cardiac remodelling, and ameliorates cardiac function. In this review, we summarize recent progress in research on galectin‐3 as a regulatory molecule involved in cardiovasc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
57
0
4

Year Published

2019
2019
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(62 citation statements)
references
References 80 publications
1
57
0
4
Order By: Relevance
“…Several of these factors are elevated in the plasma of untreated people living with HIV and, to a lesser degree, those on ART ( 27 29 ). Furthermore, many of these factors are shown to be involved in modulating metabolism and inflammation, directly involved in HIV replication, and linked to comorbidities in the general population ( 30 52 ). We investigated these immunomodulatory factors in addition to biomarkers traditionally associated with the VACS Index in a cohort of older adults living with HIV (over the age of 60) with long-term viral suppression to better understand the relationship between aging, HIV, and inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…Several of these factors are elevated in the plasma of untreated people living with HIV and, to a lesser degree, those on ART ( 27 29 ). Furthermore, many of these factors are shown to be involved in modulating metabolism and inflammation, directly involved in HIV replication, and linked to comorbidities in the general population ( 30 52 ). We investigated these immunomodulatory factors in addition to biomarkers traditionally associated with the VACS Index in a cohort of older adults living with HIV (over the age of 60) with long-term viral suppression to better understand the relationship between aging, HIV, and inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, Prkaca, an important metabolic gene, has also been shown to play an important function during CVD (Bers, 2008;Diviani et al, 2011;Turnham and Scott, 2016). Lgals3, related to acute inflammation response, has been studied intensively in recent years as a key gene in CVD, and as a potential CVD therapy target (Suthahar et al, 2018;Zhong et al, 2019). Lastly, Pprc1, as important regulator of mitochondrial biogenesis, has not been explored for its direct relationship with CVD; however, mitochondrial biogenesis appears to be an important response to CVD (Piantadosi and Suliman, 2012;Ren et al, 2010;Siasos et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…The most common systemic inflammation markers in modern risk stratification practice are High-sensitivity C-reactive Protein (hs-CRP), Lipoprotein-associated phospholipase A2 (Lp-PLA2) and Myeloperoxidase (MPO) [1,2]. Today, one of the most perspective markers are Growth Differentiation Factor 15 (GDF-15) [3,4], P-selectin [5] and Galectin-3 [6,7].…”
Section: Introductionmentioning
confidence: 99%